ADMA Biologics, Inc.ADMANASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank57
3Y CAGR-28.3%
5Y CAGR-9.9%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-28.3%/yr
vs +36.7%/yr prior
5Y CAGR
-9.9%/yr
Recent deceleration
Acceleration
-65.0pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.11M | -49.0% |
| 2024 | $13.93M | -44.3% |
| 2023 | $25.03M | +29.8% |
| 2022 | $19.28M | +47.7% |
| 2021 | $13.06M | +8.9% |
| 2020 | $11.99M | +33.3% |
| 2019 | $8.99M | +62.8% |
| 2018 | $5.52M | +68.1% |
| 2017 | $3.29M | +46.7% |
| 2016 | $2.24M | - |